Bioject Inc.

Bioject Medical Technologies is the parent company of Bioject, Inc., founded in 1985 to develop, manufacture and market advanced needle-free drug delivery systems. The Biojector 2000 Needle-Free Injection Management System delivers medications parenterally without a needle. Now there is an effective needle-free drug delivery method for subcutaneous and intramuscular injections that prevents contaminated needlestick injuries and the subsequent spread of bloodborne pathogens. Because it is easy to use and patient preferred, it marks a new standard of care for administering injections. The Biojector 2000 Needle-Free Injection Management System delivers medications parenterally without a needle. Instead, the Biojector uses compressed carbon dioxide (CO2) as a safe power source to inject medication through a micro-orifice within a fraction of a second. This delivery action effectively penetrates the skin and delivers the medication into the patients's tissue.

Activity:

Product / Technology type(s) covered:

- Drug delivery

Therapeutic targets:

Markets Covered

a. HeadQuarter:

b. Continent(s) active:

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: